Pfizer (22)
- Business Finance (7)
- Human Resources (6)
- Uncategorized (9)
- Amendment No. 3, dated as of September 18, 2020, to the Separation and Distribution Agreement, dated as of July 29, 2019, by and between Pfizer Inc. and Upjohn Inc. (Pursuant to... (Filed With SEC on November 5, 2020)
- Time Sharing Agreement, dated July 9, 2020, by and between Pfizer Inc. and Albert Bourla (Filed With SEC on August 6, 2020)
- Fourth Supplemental Indenture, dated as of May 28, 2020 (Filed With SEC on May 28, 2020)
- Amendment No. 2, dated as of May 29, 2020, to the Separation and Distribution Agreement, dated as of July 29, 2019, by and between Pfizer Inc. and Upjohn Inc (Filed With SEC on June 1, 2020)
- Amendment No. 1, dated as of May 29, 2020, to the Business Combination Agreement, dated as of July 29, 2019, by and among Pfizer Inc., Upjohn Inc., Utah Acquisition Sub Inc.,... (Filed With SEC on June 1, 2020)
- Pricing Agreement, dated May 18, 2020 (Filed With SEC on May 19, 2020)
- Underwriting Agreement, dated May 18, 2020 (Filed With SEC on May 19, 2020)
- Form of Acknowledgment and Consent and Summary of Key Terms for Grants of RSUs, TSRUs, PPSs and PSAs (Filed With SEC on May 7, 2020)
- Third Supplemental Indenture, dated as of March 27, 2020, between Pfizer Inc. and The Bank of New York Mellon, as trustee (Filed With SEC on March 27, 2020)
- Pricing Agreement, dated March 25, 2020, by and among Pfizer Inc. and BofA Securities, Inc., Credit Suisse Securities (USA) LLC and Morgan Stanley & Co. LLC, as representatives of... (Filed With SEC on March 27, 2020)
- Underwriting Agreement, dated March 25, 2020, by and among Pfizer Inc. and BofA Securities, Inc., Credit Suisse Securities (USA) LLC and Morgan Stanley & Co. LLC, as... (Filed With SEC on March 27, 2020)
- Amendment No. 2 to the Pfizer Inc. Executive Severance Plan (Filed With SEC on February 27, 2020)
- Amendment No. 7 to the Pfizer Supplemental Savings Plan (Filed With SEC on February 27, 2020)
- Description of Pfizers Securities (Filed With SEC on February 27, 2020)
- Amendment No. 1 to the Separation and Distribution Agreement, dated as of February 18, 2020, by and between Pfizer Inc. and Upjohn Inc (Filed With SEC on February 27, 2020)
- Consulting Agreement between Ian C. Read and Pfizer Inc., dated December 13, 2019 (Filed With SEC on December 19, 2019)
- Amendment No. 6 to the Pfizer Supplemental Savings Plan (Filed With SEC on August 8, 2019)
- Business Combination Agreement, dated July 29, 2019, by and among Pfizer Inc., Upjohn Inc., Utah Acquisition Sub Inc., Mylan N.V., Mylan I B.V. and Mylan II B.V (Filed With SEC on July 29, 2019)
- Separation and Distribution Agreement, dated as of July 29, 2019, by and among Pfizer Inc. and Upjohn Inc (Filed With SEC on July 29, 2019)
- Second Supplemental Indenture, dated as of March 11, 2019 (Filed With SEC on March 11, 2019)
- Pricing Agreement, dated March 4, 2019 (Filed With SEC on March 6, 2019)
- Underwriting Agreement, dated March 4, 2019 (Filed With SEC on March 6, 2019)
